Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 4Lymphoid 3Head & Neck 3Thoracic 1Sarcoma 1Other neoplasm 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Endometrial Neoplasms 1Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Cytological Techniques × Gynecologic × Clear all
NCT07148154 2025-08-29

Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations

MiMARK Diagnostics, S.L.

Recruiting
3,000 enrolled
Gynecologic

Endometrial Neoplasms

NCT05727228 2023-02-14

I-share

University of Aarhus

Recruiting
5,000 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02067468 2019-09-19

ASCUS-COL

Universidad de Antioquia

Phase NA Completed
2,661 enrolled 18 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡